Meridian Clinical Trials - Joe

Co-Founder; 13 years in specialty biopharm leadership roles from R&D to executive. Novapeutics LLC is a biopharmaceutical company spun-out from the University of Pennsylvania that aims to develop a first-in-class, oral curative therapeutic to reverse the course of diabetes by regenerating insulin-producing beta cells. Our approach utilizes small molecule therapeutics to to disrupt menin and mixed lineage leukemia (MLL) proteins, known as a menin inhibitor, which enhancing endogenous beta cell regeneration in diabetes patients. Currently with the support of the SBIR funding from NIH/NIDDK, we have identified promising novel menin inhibitors as our drug leads.

Speaker Details
Events of the Speaker
You might also love these events.
November 22, 2021
Lorem ipsum dolor sit amet, voluptua iracundia an pri, his utinam principes dignissim ad. Ne nec dolore oblique nusquam, cu luptatum volutpat delicatissimi has.
Upcoming